← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 20, 2018Last known activity
Aug 22, 2023
Timeline
2010s
- Jan 1, 2010
BECRO Ltd.— Founded
Drugs by trial phase (3 distinct, 15 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (21)
- NCT06025214CollaboratorPhase 1Aug 22, 2023
- NCT06025214Overall official - principal investigatorPhase 1Aug 22, 2023
- NCT05982990Overall official - principal investigatorPhase 1Aug 1, 2023
- NCT05982990CollaboratorPhase 1Aug 1, 2023
- NCT05697003Overall official - principal investigatorPhase 1Feb 17, 2023
- NCT05697003CollaboratorPhase 1Feb 17, 2023
- NCT05664061CollaboratorPhase 3Dec 20, 2022
- NCT05397834CollaboratorPhase 1May 11, 2022
- NCT05397834Overall official - principal investigatorPhase 1May 11, 2022
- NCT05021887CollaboratorPhase 1Aug 13, 2021
- NCT05021887Overall official - principal investigatorPhase 1Aug 13, 2021
- NCT04665895CollaboratorPhase 3Dec 10, 2020
- NCT04564456CollaboratorPhase 1Sep 22, 2020
- NCT04546256CollaboratorPhase 1Sep 1, 2020
- NCT04462822CollaboratorPhase 1Aug 24, 2020
Details
- Founded
- Athens, GR Jan 1, 2010
- Last known activity
- Aug 22, 2023
Notes
CRO